Sequana Medical NV
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sequana Medical NV
LSP says its new fund for medical device and drug development companies will be the biggest fund dedicated to life sciences companies in Europe.
One year on from its IPO on Euronext Brussels, abdominal implant maker Sequana Medical has secured €19m ($21m) in an equity placement. The company said it had been backed by new and existing investors.
Sequana Medical has reported results from the first-in-human single-dose direct sodium removal (DSR) proof-of-concept study for volume overload due to heart failure.
Sequana Medical has launched an IPO on Euronext Brussels a few days after the US FDA granted a breakthrough device designation to Sequana’s alfapump for liver ascites.
- Medical Devices